KELLY LAPA: Open Payments
NPI 1073519187 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 37 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $820 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $218 |
| Amgen Inc. | 3 | $145 |
| Astellas Pharma US Inc | 5 | $134 |
| Abbott Laboratories | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| PFIZER INC. | 3 | $55 |
| Novo Nordisk Inc | 2 | $52 |
| Lundbeck LLC | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| MicroTransponder, Inc. | 1 | $33 |
Products named: QULIPTA, Veozah, REXULTI, REPATHA, FREESTYLE LIBRE 3, UBRELVY, NURTEC ODT, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
